The Parenteral Drug Association, Inc. (PDA) and RX Global today announced the renewal of their Premier Association Sponsorship agreement for INTERPHEX 2023, taking place April 25-27, 2023, at the Javits Center in New York City. This is the tenth year PDA has served as a Premier Association Supporter.
PDA is a leading provider of science, technology and regulatory information and education, and INTERPHEX offers access to the very latest in technical sessions, cutting-edge development and manufacturing technologies and innovation to cost effectively and efficiently develop and manufacture quality product.
"Since 2014, PDA’s Sponsorship of INTERPHEX reflects the association’s interest in the continual enhancement of industry learning and improvement, areas we find present at INTERPHEX," stated Richard Johnson, President and CEO of PDA. "Our collaboration with INTERPHEX is one example of PDA’s endeavors to help our members improve their operations based on the latest science and technology to develop safe and effective medicines for patients around the world."
"Our long-term collaboration with PDA has aligned INTERPHEX with thought leaders across the globe," stated Douglas Lugo, Event Director of INTERPHEX. “Through this partnership, we are able to expand the INTERPHEX audience and deliver even more exciting content and professional development opportunities at the Show.”
Under the 2023 sponsorship agreement, PDA is developing a set of training courses for attendees of INTERPHEX.